United States · Law · S
S. 139 (114th)
Ensuring Access to Clinical Trials Act of 2015
Introduced
8 January 2015
Last action
7 October 2015 · President
Status
Became Public Law No: 114-63.
Sponsors
Ron Wyden, Sen. Hatch, Orrin G. [R-UT], Edward Markey, Sen. Brown, Sherrod [D-OH], Rep. Boxer, Barbara [D-CA-6], Amy Klobuchar, Richard Durbin, Christopher Coons, Sen. Ayotte, Kelly [R-NH], Sen. Stabenow, Debbie [D-MI], Michael Bennet, Roger Wicker, Jeanne Shaheen, Susan Collins, Rep. Roberts, Pat [R-KS-1], Kirsten Gillibrand
Subjects
Healthcare
Source updated
5 December 2025
Summary
Ensuring Access to Clinical Trials Act of 2015 This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 January 2015
Introduced
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S105; text of measure as introduced: CR S105)
Source: IntroReferral
8 January 2015
Introduced
Introduced in Senate
Source: IntroReferral
16 July 2015
Passed
Passed Senate without amendment by Unanimous Consent. (consideration: CR S5175; text as passed Senate: CR S5175)
Source: Floor
16 July 2015
Passed
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S5175; text as passed Senate: CR S5175)
Source: Floor
16 July 2015
Discharge
Senate Committee on Finance discharged by Unanimous Consent.
Source: Discharge
16 July 2015
Committee
Senate Committee on Finance discharged by Unanimous Consent.
Source: Committee
17 July 2015
Floor
Message on Senate action sent to the House.
Source: Floor
20 July 2015
Introduced
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
20 July 2015
Introduced
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
20 July 2015
Floor
Received in the House.
Source: Floor
21 July 2015
Referred
Referred to the Subcommittee on Health.
Source: Committee
24 July 2015
Referred
Referred to the Subcommittee on Health.
Source: Committee
28 September 2015
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
28 September 2015
Passed
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H6276)
Source: Floor
28 September 2015
Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H6276)
Source: Floor
28 September 2015
Floor
DEBATE - The House proceeded with forty minutes of debate on S. 139.
Source: Floor
28 September 2015
Floor
Considered under suspension of the rules. (consideration: CR H6276-6279)
Source: Floor
28 September 2015
Floor
Mr. Ryan (WI) moved to suspend the rules and pass the bill.
Source: Floor
30 September 2015
Floor
Presented to President.
Source: Floor
30 September 2015
President
Presented to President.
Source: President
7 October 2015
Became law
Became Public Law No: 114-63.
Source: President
7 October 2015
Became law
Signed by President.
Source: BecameLaw
7 October 2015
President
Signed by President.
Source: President
Votes
No vote records are attached yet.
Versions
- Enrolled Bill · undated · Official file
- Public Law · 7 October 2015 · Official file
- Referred in House · 20 July 2015 · Official file
- Engrossed in Senate · 16 July 2015 · Official file
- Introduced in Senate · 8 January 2015 · Official file
Documents
14 official files
Enrolled Bill (text)
Enrolled Bill (text)
Enrolled Bill · EN
Enrolled Bill (PDF)
Enrolled Bill · EN
Public Law (text)
Public Law · EN · 7 October 2015
Public Law (PDF)
Public Law · EN · 7 October 2015
Public Law
summary · EN · 7 October 2015
Passed House without amendment
summary · EN · 28 September 2015
Referred in House (text)
Referred in House · EN · 20 July 2015
Referred in House (PDF)
Referred in House · EN · 20 July 2015
Engrossed in Senate (text)
Engrossed in Senate · EN · 16 July 2015
Engrossed in Senate (PDF)
Engrossed in Senate · EN · 16 July 2015
Passed Senate without amendment
summary · EN · 16 July 2015
Introduced in Senate (text)
Introduced in Senate · EN · 8 January 2015
Introduced in Senate (PDF)
Introduced in Senate · EN · 8 January 2015
Introduced in Senate
summary · EN · 8 January 2015
Sponsors
- Ron Wyden · D · Sponsor
- Sen. Hatch, Orrin G. [R-UT] · R · Sponsor
- Edward Markey · D · Sponsor
- Sen. Brown, Sherrod [D-OH] · D · Sponsor
- Rep. Boxer, Barbara [D-CA-6] · D · Cosponsor
- Amy Klobuchar · D · Cosponsor
- Richard Durbin · D · Cosponsor
- Christopher Coons · D · Cosponsor
- Sen. Ayotte, Kelly [R-NH] · R · Cosponsor
- Sen. Stabenow, Debbie [D-MI] · D · Cosponsor
- Michael Bennet · D · Cosponsor
- Roger Wicker · R · Cosponsor
- Jeanne Shaheen · D · Cosponsor
- Susan Collins · R · Cosponsor
- Rep. Roberts, Pat [R-KS-1] · R · Cosponsor
- Kirsten Gillibrand · D · Cosponsor
- · hsif00 · Standing
- · hswm00 · Standing
- · ssfi00 · Standing
Related records
- related to → Ensuring Access to Clinical Trials Act of 2015
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/senate-bill/139
- Open data entity: https://api.congress.gov/v3/bill/114/s/139
- us · 114-s-139 · source updated 5 December 2025